Corona Vaccins First Dose Efficacy

Pfizer

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (BNT162b2=Pfizer/BioNTech)

Vaccinated vs Unvaccinated in BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Moderna

Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020

AstraZeneca

Cumulative incidence plot for time to first SARS-CoV-2 virologically-confirmed COVID-19 occurring post dose1

(Oxford/AstraZeneca COVID-19 vaccine AZD1222)

Janssen

Cumulative Incidence of Covid-19 with Onset at Least 1 Day after Vaccination and Vaccine Efficacy over Time.

See Also

• Vaccins
• Corona